Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Most patients with small patches of hair loss usually regrow hair.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Topical Ruxolitinib may safely treat severe hair loss.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.